Exegenesis Bio Secures Multi-Million Dollar Series B Financing for Gene Therapy Pipeline
Exegenesis Bio Inc., a leading gene therapy company, has successfully completed a Series B financing...
Exegenesis Bio Inc., a leading gene therapy company, has successfully completed a Series B financing...
Asymchem Laboratories (Tianjin) Co., Ltd, a renowned Contract Development and Manufacturing Organization (CDMO) based in...
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...